Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dedee F Murrell

Showing results (201-210 of 258) with videos related to

Pageof 26
Sort By:
The Journal of Investigative Dermatology|March 9, 2007
Retrospective diagnosis of fatal BP180-deficient non-Herlitz junctional epidermolysis bullosa suggested by immunofluorescence (IF) antigen-mapping of parental carriers bearing enamel defectsDedee F Murrell, Anna M G Pasmooij, Hendri H Pas, et al.
The Journal of Pathology|October 11, 2011
Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisitaZlatko Kopecki, Ruth M Arkell, Xanthe L Strudwick, et al.
Journal of the American Academy of Dermatology|March 23, 2020
Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional surveyVictor A Eng, Daniel C Solis, Emily S Gorell, et al.
Nature Reviews. Disease Primers|March 3, 2025
Author Correction: Bullous pemphigoidHossein Akbarialiabad, Enno Schmidt, Aikaterini Patsatsi, et al.
Pediatric Dermatology|July 9, 2010
Dilated cardiomyopathy in epidermolysis bullosa: a retrospective, multicenter studyIrene Lara-Corrales, Jemima E Mellerio, Anna E Martinez, et al.
International Journal of Women'S Dermatology|October 5, 2020
Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgarisAmir Teimourpour, Kowsar Hedayat, Fereshteh Salarvand, et al.
Journal of the American Academy of Dermatology|July 25, 2022
The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosisJoyce M C Teng, Christopher G Bunick, Scott Guenthner, et al.
Journal of the American Academy of Dermatology|December 21, 2013
Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)Clement C H Loh, Jaehwan Kim, John C Su, et al.
Dermatologic Therapy|October 6, 2022
Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab-treated and rituximab-naïve patientsElham Mazaherpour, Nika Kianfar, Shayan Dasdar, et al.
Nature Reviews. Disease Primers|February 20, 2025
Bullous pemphigoidHossein Akbarialiabad, Enno Schmidt, Aikaterini Patsatsi, et al.
Pageof 26

Showing results (201-210 of 258) with videos related to

Sort By:
Pageof 26
The Journal of Investigative Dermatology|March 9, 2007
Retrospective diagnosis of fatal BP180-deficient non-Herlitz junctional epidermolysis bullosa suggested by immunofluorescence (IF) antigen-mapping of parental carriers bearing enamel defectsDedee F Murrell, Anna M G Pasmooij, Hendri H Pas, et al.
The Journal of Pathology|October 11, 2011
Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisitaZlatko Kopecki, Ruth M Arkell, Xanthe L Strudwick, et al.
Journal of the American Academy of Dermatology|March 23, 2020
Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional surveyVictor A Eng, Daniel C Solis, Emily S Gorell, et al.
Nature Reviews. Disease Primers|March 3, 2025
Author Correction: Bullous pemphigoidHossein Akbarialiabad, Enno Schmidt, Aikaterini Patsatsi, et al.
Pediatric Dermatology|July 9, 2010
Dilated cardiomyopathy in epidermolysis bullosa: a retrospective, multicenter studyIrene Lara-Corrales, Jemima E Mellerio, Anna E Martinez, et al.
International Journal of Women'S Dermatology|October 5, 2020
Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgarisAmir Teimourpour, Kowsar Hedayat, Fereshteh Salarvand, et al.
Journal of the American Academy of Dermatology|July 25, 2022
The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosisJoyce M C Teng, Christopher G Bunick, Scott Guenthner, et al.
Journal of the American Academy of Dermatology|December 21, 2013
Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)Clement C H Loh, Jaehwan Kim, John C Su, et al.
Dermatologic Therapy|October 6, 2022
Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab-treated and rituximab-naïve patientsElham Mazaherpour, Nika Kianfar, Shayan Dasdar, et al.
Nature Reviews. Disease Primers|February 20, 2025
Bullous pemphigoidHossein Akbarialiabad, Enno Schmidt, Aikaterini Patsatsi, et al.
Pageof 26